Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide.

Authors:
C Turner
C Turner
Ninewells Hospital
United Kingdom
S Gross
S Gross
UMR 8180 CNRS Université de Versailles St Quentin en Yvelines
France

Am J Pediatr Hematol Oncol 1994 Nov;16(4):325-8

Department of Pediatrics, College of Medicine, University of Florida, Gainesville 32610-0296.

Purpose: Surgical resection of cervicofacial cystic hygromas and lymphangiomas rarely effects complete reduction because of severe anatomic restrictions.

Patients And Methods: With prior knowledge of cyclophosphamide activity against lesions of this type, a formal trial of cyclophosphamide was initiated.

Results: Overall dose escalation therapy resulted in 50% reduction in mass without recurrence after cessation of therapy and with minimal and readily reversible toxicity.

Conclusions: The favorable responses to cyclophosphamide in this study suggest that a prospective randomized trial should be initiated. Certainly, children who have airway and/or esophageal compromise who have failed surgical therapies should be considered for cyclophosphamide treatment.
November 1994
3 Reads

Publication Analysis

Top Keywords

cyclophosphamide
5
reduction mass
4
50% reduction
4
therapy 50%
4
escalation therapy
4
mass recurrence
4
recurrence cessation
4
minimal reversible
4
therapy minimal
4
cessation therapy
4
dose escalation
4
reversible toxicityconclusions
4
activity lesions
4
cyclophosphamide activity
4
knowledge cyclophosphamide
4
lesions type
4
type formal
4
initiatedresults dose
4
cyclophosphamide initiatedresults
4
formal trial
4

Similar Publications

Cervicofacial cystic hygroma. Patterns of recurrence and management of the difficult case.

Arch Otolaryngol Head Neck Surg 1991 May;117(5):546-53

Department of Otolaryngology-Head Neck Surgery, University of Washington, Seattle 98195.

Cystic hygromas usually present in infancy or early childhood as compressible masses that may rapidly and intermittently enlarge. While they may arise in any anatomic location, hygromas of the head and neck are especially difficult to manage since enlargement may cause serious sequela such as airway obstruction, feeding difficulties, and speech pathology. Complete extirpation of these lesions is often impossible, and recurrence rates are accordingly high. Read More

View Article
May 1991

Surgical treatment of cervicofacial cystic hygromas in children.

ORL J Otorhinolaryngol Relat Spec 2005 1;67(6):331-4. Epub 2005 Dec 1.

Department of Pediatric Surgery, Gazi University Medical Faculty, Emek, Turkey.

Aim: The aim of this study was to evaluate the results of surgical treatment of cervicofacial cystic hygromas in children.

Patients And Methods: Medical records of 17 patients who were operated for cervicofacial cystic hygroma between 1985 and 2004 were evaluated in terms of age, gender, symptoms, diagnostic workups, outcomes and complications.

Results: There was a slight male predominance -- 10 (59%) boys and 7 (41%) girls. Read More

View Article
April 2006

[New treatment of cystic hygromas/lymphangiomas].

Ugeskr Laeger 2005 Apr;167(14):1505-8

H:S Rigshospitalet, Ore-, Nase- og Halskirurgisk Klinik, Kobenhavn.

View Article
April 2005